Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?

OBJECTIVE: Disease-modifying osteoarthritis drugs (DMOADs) are under development. Our goal was to determine efficacy, toxicity, and cost thresholds under which DMOADs would be a cost-effective knee OA treatment. DESIGN: We used the Osteoarthritis Policy Model, a validated computer simulation of knee...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Losina, Elena, Daigle, Meghan E., Reichmann, William M., Suter, Lisa G., Hunter, David J., Solomon, Daniel H., Walensky, Rochelle P., Jordan, Joanne M., Burbine, Sara A., Paltiel, A. David, Katz, Jeffrey N.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3670115/
https://ncbi.nlm.nih.gov/pubmed/23380251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.joca.2013.01.016
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars